Exo

Exo, with the slogan "Point-of-Care Answers," is a pioneering medical imaging software and devices company. Founded in 2015 and headquartered in the United States, Exo is dedicated to providing global access to high-quality, affordable, and user-friendly medical imaging. The company is driving the modernization of medical imaging by integrating its high-performance ultrasound platform with artificial intelligence. This innovative approach aims to empower healthcare professionals to make real-time, critical decisions, consequently enhancing patient outcomes. Exo's comprehensive ecosystem encompasses high-performance imaging, FDA-cleared AI, and workflow software designed to simplify medical imaging to the level of using a smartphone. In July 2021, the company secured a significant $220.00M Series C investment from a group of prominent investors, including Pura Vida Investments, RA Capital Management, BlackRock, Sands Capital Ventures, Longevity Vision Fund, Page One Ventures, and Avidity Partners. The collaboration with these influential investors reflects the confidence in Exo's vision and solutions within the Health Care industry.